Irish pharma trade group IPHA launches medicines.ie on facebook

13 March 2011

Independently approved, high-quality information on medicines in Ireland is now available on facebook for the first time, the Irish Pharmaceutical Healthcare Association (IPHA) announced last week.

IMB research indicates that one in four people in Ireland source important health information on-line and that it influences the choice of medicine or treatment for half (49%) of those who use it, noted the IPHA.

Having trustworthy information on how medicines work, details of how to take them properly and any possible side effects, can have a dramatic effect on people’s lives and well-being, helping them stay healthy and keep active. Being knowledgeable about their medicines can keep people out of hospital as their illness or condition is managed properly and less likely to deteriorate. This was the message at the launch of medicines.ie on facebook

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical